Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2013 | 01-2013 | 10-2012 | 07-2012 | 04-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,330 | -4,284 | -3,297 | -1,323 | -8,661 |
| Depreciation Amortization | 203 | 153 | 103 | 54 | 105 |
| Accounts receivable | 84 | -58 | -43 | -55 | 1 |
| Accounts payable and accrued liabilities | -472 | -574 | -467 | -385 | 96 |
| Other Working Capital | -625 | -956 | -491 | -991 | 423 |
| Other Operating Activity | 2,838 | 2,587 | 1,641 | 894 | 2,809 |
| Operating Cash Flow | $-4,302 | $-3,132 | $-2,554 | $-1,806 | $-5,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -35 | -28 | -19 | -519 |
| Investing Cash Flow | $-57 | $-35 | $-28 | $-19 | $-519 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,141 | 9,195 | N/A | 0 | 97 |
| Financing Cash Flow | $9,141 | $9,195 | $0 | $0 | $97 |
| Exchange Rate Effect | 25 | 25 | 27 | 25 | -54 |
| Beginning Cash Position | 4,754 | 4,716 | 4,716 | 4,716 | 10,457 |
| End Cash Position | 9,561 | 10,769 | 2,161 | 2,916 | 4,754 |
| Net Cash Flow | $4,807 | $6,053 | $-2,555 | $-1,800 | $-5,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,302 | -3,132 | -2,554 | -1,806 | -5,227 |
| Capital Expenditure | -57 | -35 | -28 | -19 | -519 |
| Free Cash Flow | -4,359 | -3,167 | -2,582 | -1,825 | -5,746 |